4//SEC Filing
HAEMONETICS CORP 4
Accession 0000313143-14-000073
$HAECIK 0000313143operating
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 7:12 PM ET
Size
9.6 KB
Accession
0000313143-14-000073
Insider Transaction Report
Form 4
Davies Kent J
President, Global Markets
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2014-07-22+34,271→ 34,271 totalExercise: $35.27From: 2015-07-25Exp: 2024-07-22→ Common Stock (34,271 underlying) - Award
Performance Shares
2014-07-22+19,577→ 19,577 totalExercise: $0.00From: 2017-03-31Exp: 2017-12-31→ Common Stock (19,577 underlying) - Award
Common Stock
2014-07-22+3,402→ 3,402 total
Footnotes (3)
- [F1]Restricted Stock Unit Grant which vest 25% per year over 4 years following the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan.
- [F2]Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
- [F3]Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Companys stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d).
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0000313143
Filing Metadata
- Form type
- 4
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 7:12 PM ET
- Size
- 9.6 KB